Guideline Adherence Regarding the Use of Expensive Drugs in Daily Practice: The Examples of Trastuzumab in Breast Cancer and Bortezomib in Multiple Myeloma

Publisher： Karger

E-ISSN： 2296-5262|39|7-8|417-422

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.39, Iss.7-8, 2016-06, pp. : 417-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib-Induced Rhabdomyolysis in Multiple Myeloma

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

Is Guideline Adherence the Key to Increased Survival in Patients with Breast Cancer?

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 301-302

Karger

Access to resources Recommend Favorite

A Systematic Review on the Use of Bortezomib in Multiple Myeloma Patients with Renal Impairment: What Is the Published Evidence?

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 163-168

Karger

Access to resources Recommend Favorite

The effects of bortezomib on bone disease in patients with multiple myeloma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 170-173

Karger

Access to resources Recommend Favorite